150 related articles for article (PubMed ID: 24557479)
21. Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b study.
Younes A; Thieblemont C; Morschhauser F; Flinn I; Friedberg JW; Amorim S; Hivert B; Westin J; Vermeulen J; Bandyopadhyay N; de Vries R; Balasubramanian S; Hellemans P; Smit JW; Fourneau N; Oki Y
Lancet Oncol; 2014 Aug; 15(9):1019-26. PubMed ID: 25042202
[TBL] [Abstract][Full Text] [Related]
22. Rituximab and bendamustine in patients with CD20+ diffuse large B-cell lymphoma not eligible for cyclophosphamide, doxorubicin, vincristine and prednisone-like chemotherapy.
Walter E; Schmitt T; Dietrich S; Ho A; Witzens-Harig M
Leuk Lymphoma; 2012 Nov; 53(11):2290-2. PubMed ID: 22475324
[No Abstract] [Full Text] [Related]
23. Extreme exigency in the extremity: an illustrative case of diffuse large B-cell lymphoma occurring in the arm.
Abid MB; Wang S; Loi HY; Chan EHL; Poon LM; de Mel S
Singapore Med J; 2018 Jul; 59(7):397-398. PubMed ID: 30109350
[No Abstract] [Full Text] [Related]
24. [How to improve the efficacy of R-CHOP for indolent B-cell lymphoma?].
Tobinai K
Rinsho Ketsueki; 2012 Jun; 53(6):609-17. PubMed ID: 22790636
[No Abstract] [Full Text] [Related]
25. R-CHOP versus dose-adjusted R-EPOCH in frontline management of primary mediastinal B-cell lymphoma: a multi-centre analysis.
Shah NN; Szabo A; Huntington SF; Epperla N; Reddy N; Ganguly S; Vose J; Obiozor C; Faruqi F; Kovach AE; Costa LJ; Xavier AC; Okal R; Kanate AS; Ghosh N; Kharfan-Dabaja MA; Strelec L; Hamadani M; Fenske TS; Calzada O; Cohen JB; Chavez J; Svoboda J
Br J Haematol; 2018 Feb; 180(4):534-544. PubMed ID: 29265182
[TBL] [Abstract][Full Text] [Related]
26. Successful treatment of diffuse large B-cell non-hodgkin lymphoma with modified CHOP (cyclophosphamide/doxorubicin/vincristine/prednisone) chemotherapy and rituximab in a patient with Nijmegen syndrome.
Dumic M; Radman I; Krnic N; Nola M; Kusec R; Begovic D; Labar B; Rados M
Clin Lymphoma Myeloma; 2007 Nov; 7(9):590-3. PubMed ID: 18186968
[TBL] [Abstract][Full Text] [Related]
27. Histological analysis on adhesive molecules of renal intravascular large B cell lymphoma treated with CHOP chemotherapy and rituximab.
Kusaba T; Hatta T; Tanda S; Kameyama H; Tamagaki K; Okigaki M; Inaba T; Shimazaki C; Sasaki S
Clin Nephrol; 2006 Mar; 65(3):222-6. PubMed ID: 16550755
[TBL] [Abstract][Full Text] [Related]
28. [Lymphoproliferative disease following kidney transplantation].
Merkle M; Rupprecht HD
Dtsch Med Wochenschr; 2005 Jul; 130(28-29):1691-4. PubMed ID: 16003604
[TBL] [Abstract][Full Text] [Related]
29. Successful treatment of diffuse large B-cell lymphoma following Waldenström's macroglobulinemia with CHOP chemotherapy followed by combination therapy of CHOP with rituximab.
Uchino K; Sameshima H; Miyamoto T; Iino T; Kato K; Henzan H; Aoki K; Nagafuji K; Gondo H; Harada M
Intern Med; 2004 Feb; 43(2):131-4. PubMed ID: 15005256
[TBL] [Abstract][Full Text] [Related]
30. [Cicatricial small intestinal stenosis following chemotherapy for a gastrointestinal lymphoma].
Libicher M; Lamade W; Kasperk C; Grenacher L; Kauffmann GW
Dtsch Med Wochenschr; 1996 Nov; 121(44):1359-62. PubMed ID: 8964221
[TBL] [Abstract][Full Text] [Related]
31. [A 63-old patient with right-sided hypogastric pain at 6 months after appendectomy].
Handschin D; Zeller A; Wiesner W; Buess M
Praxis (Bern 1994); 2004 Jan; 93(1-2):24-6. PubMed ID: 14964041
[No Abstract] [Full Text] [Related]
32. Sole rearrangement but not amplification of MYC is associated with a poor prognosis in patients with diffuse large B cell lymphoma and B cell lymphoma unclassifiable.
Landsburg DJ; Falkiewicz MK; Petrich AM; Chu BA; Behdad A; Li S; Medeiros LJ; Cassaday RD; Reddy NM; Bast MA; Vose JM; Kruczek KR; Smith SE; Patel P; Hernandez-Ilizaliturri F; Karmali R; Rajguru S; Yang DT; Maly JJ; Blum KA; Zhao W; Vanslambrouck C; Nabhan C
Br J Haematol; 2016 Nov; 175(4):631-640. PubMed ID: 27469075
[TBL] [Abstract][Full Text] [Related]
33. Guillain-Barre syndrome in a patient with diffuse large B-cell lymphoma, and rituximab maintenance therapy. An association beyond anecdotal evidence?
Carmona A; Alonso JD; de las Heras M; Navarrete A
Clin Transl Oncol; 2006 Oct; 8(10):764-6. PubMed ID: 17074678
[TBL] [Abstract][Full Text] [Related]
34. Anti-CD20 antibody therapy for B-cell lymphomas.
Maloney DG
N Engl J Med; 2012 May; 366(21):2008-16. PubMed ID: 22621628
[No Abstract] [Full Text] [Related]
35. Primary ovarian lymphoma--a rare entity.
Afshan A; Sadaf N
J Pak Med Assoc; 2013 Apr; 63(4):519-20. PubMed ID: 23905454
[TBL] [Abstract][Full Text] [Related]
36. Intravascular lymphomatosis.
Oei ME; Kraft GH; Sarnat HB
Muscle Nerve; 2002 May; 25(5):742-746. PubMed ID: 11994970
[TBL] [Abstract][Full Text] [Related]
37. Molecular Risk Stratification in Aggressive B-Cell Lymphomas.
Frosch ZAK; Landsburg DJ
J Clin Oncol; 2020 Jun; 38(18):2014-2017. PubMed ID: 32243222
[No Abstract] [Full Text] [Related]
38. Enteropathy-type T-cell lymphoma showing repeated small bowel rupture and refractoriness to chemotherapy: a case report.
Kataoka I; Arima F; Nishimoto J; Watanabe T; Kobayashi Y; Tamura R; Yamamoto S; Matsuno Y; Shimoda T; Tobinai K
Jpn J Clin Oncol; 2002 Dec; 32(12):546-9. PubMed ID: 12578905
[TBL] [Abstract][Full Text] [Related]
39. Is radiotherapy still necessary for diffuse large B-cell lymphoma therapy?
Mondello P; Cuzzocrea S; Pitini V; Aloisi C; Mian M
Acta Oncol; 2015 Jun; 54(6):953-5. PubMed ID: 25831143
[No Abstract] [Full Text] [Related]
40. Progressive sclerodermoid skin changes--quiz case.
Dacso MM; Petitt MS; Berlingeri-Ramos AC; Kelly BC
Arch Dermatol; 2012 Feb; 148(2):247-52. PubMed ID: 22351831
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]